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ABSTRACT 
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An Analysis with In Vivo Neutron Activation. (August 19B4) 
Scott Howard Loeffler, B. S. , Yanderbilt University; 
Drs. , State University of Utrecht 
Chairman of Advisory Committee: Dr. Leon H. Russell 
I 
Eight adult Cebus 
~a ella/Cebus albifrons were studied to 
determine the effects of an 11-week graded dosage treatment with 
cortisone acetate followed by a 5-week treatment with hydrocortisone. 
Four experimental monkeys received sequentially an aqueous suspension 
of cortisone acetate in daily injections of 5 mg/kg body weight (b. w. ) 
for four weeks, 10 mg/kg b. w. for three weeks, and 35 mg/kg for four 
weeks. This was immediately followed by a 5-week, daily treatment 
with aqueous hydrocortisone succinate at a dose of 26 mg/kg b. w. /day. 
All drugs were given by intramuscular injection. Body calcium in the 
leg and spinal regions was monitored by regional activation analysis 
employing a Cf neutron source. Serum cortisol, serum electrolytes 
(Ca +, Mg +, K+ and Na ), urinary calcium and a few routine 
hematological indices (Ht, Hb, RBC, WBC) were tested during this 
period. Control animals received no injections, but were tested in 
the same manner. Serum cortisol was elevated (p & . 05) and weight 
losses occurred in the treated group. Bone calcium (expressed as 
corrected counts) was unchanged (p & . 05), although urinary calcium 
excretion appeared to be elevated in the treated group. An 
experimental animal which died during the last weeks of the experiment 
displayed atrophy and fatty infiltration of the adrenal glands at 
post-mortem histological examination. There were no changes in serum 
electrolytes or hematological indices as measured except for an 
occasional upward fluctuation of the hematocrit in experimental 
monkeys. Regional in vivo activation analysis for measurement of 
spinal and leg calcium had a coefficient of variation of 3. 25%. 
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CHAPTER I 
INTRODUCTION 
In 1968, the Food and Nutrition Board of the National Academy of 
Sciences cited osteoporosis as a major cause of human illness, 
especially among the elderly (1). More prevalent among post- 
menopausal women (2, 3), this disease has been estimated to afflict 
from ten to thirty percent of those people in western countries above 
the age of fifty, depending upon age and sex. This phenomenon called 
osteoporosis is also associated with factors independent of age, such 
as: bedrest or immobilisation (4, 5, 6), spaceflight (7, 8), relative or 
absolute deficiencies in calcium uptake (9, 10), exogenous or 
endogenous elevations of plasma glucocorticoid levels (11, 12), renal 
insufficiency (13), thyroid disease (14), acromegaly (15) as well as 
other metabolic diseases. To say the least, the relationship of bone 
metabolism to osteoporosis is complex and the reader is referred to 
two review articles (16, 17). 
Current research on osteoporosis can legitimately be broken down 
into three principal divisions: 1) the methodological improvement for 
the early detection of bone changes; 2) endocrinological and cellular 
research on bone metabolism; and 3) clinical and experimental studies 
. to arrest or reverse bone changes once they begin to occur. 
Various studies have shown that the limited physical activity and 
weightlessness associated with spaceflight have a negative effect on 
This paper is styled after The Journal of Clinical Investi ation. 
bone (18, 19). These changes were sometimes accompanied by a rise in 
plasma cortisol levels (18). Likewise, tests in rabbits given a daily 
dose of cortisone showed increased resorption activity (20). At the 
time of these experiments there were no publications, to the author' s 
knowledge, on the relation between glucocorticoid treatments and 
osteoporosis in monkeys. 
The objectives of this thesis were as follows: 1) to investigate 
the Cebus monkey as a possible model for corticosteroid- or 
spaceflight-induced osteoporosis in humans; 2) to determine the 
calcium changes on a regional basis using neutron activation analysis 
in an animal with a skeletal structure similar to man; and 3) to 
obtain serum and urine electrolyte values as well as serum cortisol 
values during the therapy for comparison with controls. The Cebus 
monkey was chosen because of its small size and availability. 
Abbreviations used in this paper: BMC, bone mineral content; CS- 
OP, corticosteroid-induced osteoporosis; TBNAA, total-body neutron 
activation analysis; PBNAA, partial-body neutron activation analysis; 
TBBM, total body bone mineral; TBCa, total body calcium; TBV, 
trabecular bone volume; SPA, single-photon absorptiometry; and DPA, 
dual-photon absorptiometry. 
CHAPTER II 
LITERATURE REVIEW 
Osteo orosis in Animal Models 
Because experiments on human subJects cannot be done for ethical 
and practical reasons (control of diet, etc. ), it is important that 
animal models be available for research on human diseases. While 
mice, rats, monkeys, dogs and other animals have proven themselves as 
reliable models for various human disease states (for example, mammary 
tumors by the bitch), there is no especially suited animal for 
osteoporosis research. Even more exasperating is the conclusion in a 
recent book concerning animal models for human disease: there are no 
animals listed for bone metabolism studies (21)! The question then 
presents itself, "How does one induce a bone loss in animals which 
resembles osteoporosis in man?" In this section, the author will 
examine several methods which have been used. 
Calcium deficienc . The most obvious and perhaps the oldest 
method of inducing bone resorption is the feeding of a diet, complete 
in all nutrients except calcium. Bone mineral is composed of about 
39K calcium, the inorganic matrix resembling closely that of calcium 
hydroxyapatite (CaIO(P04)6'(OH)2) (22). Lack of calcium in the diet 
causes the body to call on its reserves in bone via a parathyroid 
hormone (PTH)-directed mechanism. Bone loss via this pathway has been 
used successfully in experiments with monkeys (10, 23) and rats (24- 
26). The question arises, however, as to whether or not this is the 
same kind of osteoporosis which frequently occurs in western man. The 
presence of sufficient calcium in the diets of those who have 
experienced senile, immobilization or spaceflight osteoporosis and the 
fact that calcium when given intravenously does little to restore 
osteoporotic bone to its normal state (27), would suggest that: I) 
either other factors play a role in osteoporosis, and/or, 2) as Bollet 
suggests (28), we are dealing with different types of osteoporoses. 
Immobilization. Immobilization or disuse is a second manner to 
induce osteoporosis in rats (29, 30), rabbits (31, 32), man (33), dogs 
(34-36), and monkeys (37, 38). This is usually accomplished by either 
providing the subject with a very limited space (38), suspension of 
the hindquarters in a sling (30), casting an extremity in plaster 
(32, 34), or resection of a motoric nerve (36). This method of 
induction is consistent with the theory of Urist and Adams (39) that 
bone formation is regulated by mechanical stress. A disadvantage to 
this method is the extreme discomfort and psychological stress 
(especially to the very active normal monkey) inflicted upon the 
animal. It is clear from research by Mack (38) that earthbound 
controls who were similarly restrained lost less bone than 
experimental monkeys in spaceflight. It is unclear as to whether or 
not this increased bone loss is due to other factors or merely to less 
mechanical stress encountered during weightlessness. 
~Sacefti ht ia . (40, 41), 0 h ys (30) 4 ts (43) th is 
a loss of bone density which occurs during spaceflights of greater 
than one week duration. This method of induction is obviously beyond 
the costs of all research institutes not affiliated with a space 
program; and even for those laboratories, the possibilities for large 
animal groups and frequent measurements of various metabolic functions 
are beyond the current technical capabilities. However, it is 
noteworthy for research into the endocrinology of osteoporosis that 
scientists have speculated that psychological stress could be an 
important factor in the differences found between space-bound apes and 
their controls (38). A support for the theory that these animals 
undergo a stress is the fact that rats develop a hypertrophy of the 
adrenal glands during spaceflight (42). The adrenal glands are also 
the centers of production for endogenous glucocorticoids. 
Corticosteroid-induced osteo orosis CS-OP . In 1958, Urist (43) 
pointed out that osteoporosis had only been produced in rabbits and 
birds using a cortisone or a combination of cortisone and ACTH (an 
adrenal stimulator released by the pituitary). Excluding man, this 
list has not been expanded, as yet. Jaffe and Epstein (44) noted 
generalized muscle atrophy and bone loss in rabbits after five weeks 
of a nine-week study using cortisone. Likewise, Thompson et al. (45) 
showed significant body weight and bone mineral losses in a rabbit 
study of a similar duration at doses of 15 mg/kg b. w. /day. Other 
authors (46-48) have also induced bone losses in rabbits. 
Yasamura et al. (49), on the other hand, were unable to produce 
bone losses in rats given hydrocortisone at a rate of 12 mg/kg 
b. w. /alternate days. In fact, these rats showed an increase in bone 
density as measured by TBNAA. These findings are consistent with 
those of Follis (50) who demonstrated that glucocorticoids had an 
inhibitory effect on bone resorption in rats. Moreover, neither was 
Beneton et al. (51) able to produce bone changes in cynomolgus monkeys 
with doses of a synthetic product (deflazacort) analogous to 
cortisone. In dogs, although Cushing's syndrome occurs naturally as 
well as after excessive cortisone treatments, to the author' s 
knowledge, there is no documentation on osteoporosis as a result. 
Corticosteroid Interactions: Theories of CS-OP 
Since Cushing's original study of adrenal hypercortisonism in 
1932 (52), many researchers have studied the effects of glucocorti- 
coids on bone. Since 1948, with the introduction of cortisone as 
drug, the side-effects of these powerful compounds have become 
apparent. In 1957, Pietrogrande and Mastromarino (53) noted the 
relationship between steroid therapy and osteoporosis in a report of a 
43-year-old man who had been treated continuously over a four year 
period with cortisone. Murray (54), three years later, noted 
significant radiological changes in patients receiving cortico- 
steroids. Several authors (44, 55) have shown that CS-OP is a result 
of both low bone formation and high bone resorption rates. Bressot et 
al. (56) concluded that humans receiving long-term corticosteroids 
display a general loss of trabecular bone volume (TBV) as a result of 
increased osteoid resorption and a decrease in osteoblastic apposi- 
tional rate when iliac crest biopsies were examined. He attributed 
these changes to a total increase in basic multicellular units (BMU), 
combined with a relative decrease in the activity of the osteoblasts, 
giving the osteoblasts in each BMU an advantage. 
How these changes in the number of cells and their activity ar1se 
is a subject of intense speculation. The central issue is: I) do 
corticosteroids act d1rectly on the cells involved, or 2) do 
corticosteroids act via circulating hormones such as vitamin D3, 
parathyroid hormone, estrogens and calciton1n, or 3) both of the 
above. The degree to wh1ch effects on bone occur is no doubt related 
to the biological properties of the specific corticosteroids. In 
Table I some of these properties are listed. 
Meunier et al. (55) noted a decrease in serum 25-OH D3 (vitamin D 
precursor) and a slight rise 1n serum PTH values in 70 osteoporosis 
pat1ents on corticosteroid regimens. Bernini et al. (57) found a 
signif1cantly depressed response (to calcium infusion) of calciton1n 
in patients who had received prednisone and betamethasone prior to the 
response test. This depressed response was not observed in the 
patients who had received deflazacort therapy. A "bone-saving" effect 
has also been attributed to deflazacort by others (58, 59). Russell 
and Avioli (59) found that prednisone (in vitro) inhibited the 
glycolytic pathway, which is necessary for bone calcification in 
epiphyseal cartilage, but deflazacort did not. These findings must be 
taken into account when drawing conclusions from the monkey experiment 
cited earlier (51). 
Support for the theory that corticosteroids act. directly on cells 
was provided by Chen and Feldman (60). In cultured bone cells, 
dexamethasone had the effect of potentiating the cAMP production by 
PTH; increased amounts of 1, 25(OH)203 in bone cells were found as 
well. A similar result was descr1bed by Teitelbaum (61), who not only 
TABLE 1 
Properties of Corticosteroids 
Steroid name 
Hal f-l i fe 
time (min) 
Relative anti- 
imflanvaatory effect 
(potential) 
Cortisol 
Corticosterone 
Cortisone 
Prednisone 
Dexamethasone 
Deflazacort 
80 - 100 
60 — 80 
30 
60 
200 
Not available 
1. 0 
0. 4 
0. 8 
4. 0 
25. 0 
Not available 
(Biological data in man) 
(Adopted from data in: Peterson, R. E. Metabolism of Corticosteroids 
in Man. Ann. N. Y. Acad. Sci. 82:846; Gilman, G. G. , L. S. Goodman, and 
A. Gilman (eds. ), The Pharmacolo ical Basis of Thera eutics, 6th ed. 
MacMillan Publishing Co. , N. Y. , 1980. 
recognized an increased production of cAMP in the presence of 
cortisol, but also noted that the longevity of cytosol receptors for 
1, 25(OH)2D3 was increased. In this case, the fall in serum vitamin D 
may be secondary. 
It is also possible that cortisol may regulate cell activity via 
prostaglandins. Raisz and Chyun (62) showed that a depressed cell 
proliferation and DNA synthesis in rat calvaria (induced by cortisol) 
could be reversed by the addition of PGE2 (prostaglandin) to the 
culture medium. For further details on this subject, the reader is 
referred to a review by Ibbotson et al. (17). 
Methods of Dia nosis 
In order to recognize small bone changes caused by osteoporosis 
it is necessary to make sensitive and frequent measurements during its 
early stages. There are several methods available to measure these 
changes, the most important of which are discussed below. 
~R di io . U tii the igdg'a. adiog aphy a th o iy ideiy 
available method for measuring bone density without taking a biopsy. 
The problems with this method are that photographic standardization is 
difficult (due to small differences in film quality and development 
techniques) and density changes of at least 15% must take place in 
order to be detected easily. Moreover, any such visual evaluation is 
dependent upon intra- and inter-observer errors. Hecause of the 
subjectivity involved in evaluating hypertransparency of films, some 
authors (55) accept only vertebral crush fractures or femoral neck, 
wrist or rib fractures as valid radiological evidence of osteoporosis. 
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Kovarik and Kuster (63) discuss some of the uses of this method in a 
recent article. 
Radiolo with film densitometr . One means of overcoming the 
problems of standardization and observer error is with the method 
employed at the Texas Women's University (40). A normal radiograph 
can be calibrated by placing an aluminum wedge (see Figure 1) next to 
the bone during film exposure. This alloy wedge exhibits an X-ray 
absorption coefficient similar to bone and can be standardized to 
mass-equivalents of calcium hydroxyapatite. Bone mass can be 
determined as wedge mass-equivalency by means of a densitometer which 
scans the wedge and bone sections on the developed X-ray film. This 
method has the advantage of: 1) the fact that positioning of the bone 
is not extremely critical because the complete bone section can be 
analyzed by the scanning densitometer; 2) rem exposure to the patient 
is not greater than with a normal radiograph; and 3) the system may be 
used in conjunction with several Roentgen machines as long as they are 
calibrated with phantoms (mineral substances impregnated in an organic 
matrix) and aluminum wedges are used. The disadvantage of this set-up 
probably lies in the costs of a densitometer-computer assembly in 
addition to the fact that accuracy is limited by a maximum film 
quality. 
Bone bio s -histomor hometr . A widely used method of deter- 
mining the osteoporotic status of a subject is the iliac crest biopsy 
combined with the microscopic measurement of various parameters. An 
obvious advantage of this method is that one is able to measure 
~ ~ ~ ~ ~ 
~ ~ ~ ~ ~ ~ ~ 
~ ~ 
~ ~ ~ 
~ ~ ~ ~ ~ ~ 
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simultaneously a large number of parameters such as: TBV, calcifi- 
cation rate, osteoid thickness, and resorption surface (55). The tra- 
becular bone volume (TBV), for example, is measured by determining the 
percentage of trabecular bone in the total spongiosa by means of an 
image analyzing computer which scans the section with a light beam. 
Meunier et al. (55) has noted thai a high degree of correlation 
existed between vertebral crush fractures and a TBV of less than 11%. 
This method of measuring trabecular bone seems to have slowly replaced 
the microradiography method of Jowsey and Riggs (64). The disad- 
vantages of bone biopsies are: I) a slight change in location may 
produce a significant change in the measurement; 2) the diffi- 
culty/discomfort of frequent biopsies; and 3) the questionable 
representativity of the iliac crest (chosen primarily for ease of 
access) for other body areas. 
Sin le hoton absor tiometr SPA . This method of bone mineral 
measurement first described by Cameron and Sorenson (65) and 
commercially available (Norland Instruments, WI) has the advantage of 
being cheaper and more portable than, for example, DPA and PBNAA 
techniques. The linear bone density, expressed as bone mineral 
content (BMC) over a I/8" thick scan site of the mid-distal radius, is 
usually measured. Using photon energy from an I source with 
collimator, the bone is scanned over its width and the baseline value 
due to soft tissue absorption is subtracted. The limited penetration 
of the beam from the source and the need to place the extremity in a 
soft tissue equivalent medium during measurements, limit the use of 
this machine to forearm, hands and feet (or perhaps a child's leg). 
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It has been shown that the BMC values of bones are linearly related to 
the breaking strength (66, 67); yet this method measures BMC at a point 
(mid-distal radius) which is &75% cortical bone while the vertebrae 
are predominantly trabecular bone. Riggs et al. (2) have shown that 
trabecular bone in the axial skeleton loses proportionately more 
mineral in osteoporosis and that either whole body or extremity 
(rad1us) mineral measurements are less discriminatory than vertebral 
measurements. 
Dual baton absor tiometr DPA . This recent 1mprovement on SPA 
employs a source, 3Gd, with a dichromatic beam and a greater tissue 
penetration. It can be used for either whole body (68) or regional 
body (69) scans. In short, this method differs from the above- 
mentioned Cameron technique by transmitting and measuring the 
absorption of two separate photon energies which travel through bone 
and soft tissue. This method eliminates the need for a constant soft 
tissue thickness and bones which are more thickly covered w1th tissue 
can also be measured. Edges of bone and vertebral disks can be 
distinguished by a computer which makes point by point determinations 
of density; thus, problems with positioning can be more easily 
corrected than with SPA. Riggs et al. (2) found a coefficient of 
variation (C. V. ) of 2. 3X in multiple measurements on f1ve volunteers. 
The same author had less precision in rad1us measurements with SPA 
(C. V. 3-5%), but others (70, 71) have shown the precision of 
measurements with SPA to be of the same order (C. V. 1-3%) when water 
baths are used and care 1s taken with repositioning. The advantages 
of regional BMC measurements of the vertebrae have already been 
mentioned (as a disadvantage of SPA). Further, DPA shares with SPA 
the advantage of a small radiation dose to the subject. To cite two 
practical comparisons: I) a set of four scans of the radius with a 
Norland-Cameron Bone Mineral Analyzer exposes the patient to about 
I/100 of the dose delivered to a patient for a radiograph of the 
forearm; and 2) the radiation exposure for a whole body TBBM 
measurement with DPA was 500-5000 times smaller than for a TBNAA 
measurement for calcium (71, 72). These low doses allow for frequent 
measurements with little radiation exposure. 
Neutron activation anal sis NAA . The technique of neutron ac- 
tivation analysis of body elements in viva has been extensively 
described by various authors (72-81). The method utilizes the fact 
that a living subject contains certain quantities of elemental 
nuclides which can be activated (used to generate small quantitftes of 
detectable radioactive isotopes) by collision with neutrons (n). A 
few of the generated nuclides are: Ca(n, y) Ca; 2 Na(n, v)2 Na; 
CI(n, y) Cl; AN(n, 2n) N and K(n, 2n) K. These radionuclides 
decay at various (half-life) rates, giving off energy which can be 
measured. By determining the ganvna energy output of a given 
radionuclide in its specific millivolt range per time unit, one can 
estimate the amount of element present in the irradiated body part for 
a given neutron dosage by standardization procedures with phantoms 
(known amounts of mineral embedded in a matrix shaped to the geometric 
form of the body part to be measured). It is, of course, necessary 
that the neutron beam directed towards the subject creates an 
homogenous distribution of neutrons (neutron flux) within the area to 
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be measured in order for all elementary atoms in the activated body 
region to have a statistically "equal chance" to become activated. 
Body thickness, distance from the point source to the body surface, 
and the type of neutron source (determines the percentage of neutrons 
which are of sufficient energy to pass through several inches of flesh 
and bone) are all factors which must be considered in developing 
facilities and using NAA methods. 
Basically, the techniques used in human and animal studies are 
either of the whole-body (TBNAA) (72-77) or partial-body (PBNAA) (78- 
81) type. The advantage of TBNAA lies in the determination of total 
Na, K, N, P and Cl besides the already mentioned measurement of 
calcium for osteoporosis status. Local or regional measurement of the 
former elements has little use unless the results can be converted to 
whole body equivalents. Total body potassium can be used for 
estimating body fat, nitrogen for estimating body protein and sodium 
for electrolyte studies (75). Total body Ca (TBCa) measurements may 
be the only feasible measurement in small animals such as rats (82), 
but, in man, the axial skeleton is thought to be the best indicator of 
osteoporosis associated with old age (2). The high correlation 
between bone mineral measurements in the distal radius and total body 
Ca (r = 0. 93 - 0. 98) would seemingly make the greater radiation 
exposure to subjects inherent in TBNAA unnecessary (80, 83). This 
finding emphasizes the importance of regional methods for measuring 
axial bone mineral. 
The advantage of a smaller radiation dose to the subject with 
PBNAA in comparison to TBNAA is made possible by the smaller source to 
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skin distance which allows a weaker neutron source to be employed (to 
radiate a large object adequately, one must employ a stronger source 
at a greater distance). This is important with respect to the total 
neutron exposure of the subject. The growing concern over neutron 
exposure can best be expressed by a recent statement of The National 
Council on Radiation Protection (NCRP): "Although, at present, there 
is a recommended limit on neutron dosage, this may soon be reduced to 
an even smaller limit. "(84) An accurate assessment of vertebral 
mineral and calcium content is currently available with regional DPA 
and PBNAA, respectively. Regional trunk calcium as measured by 
activation analysis and regional trunk mineral as measured by DPA are 
about equally precise (C. V. 1-2%) and correlation between the two is 
high (r = 0. 97) (85). The disadvantage of a greater radiation 
exposure with PBNAA when compared to regional DPA is probably less 
than the 500-5000x difference stated above for whole body measure- 
ments. Because of the growing importance of regional measurements in 
man and the similarity in skeletal structure between the species, the 
monkey seemed an ideal model for testing PBNAA. 
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CHAPTER III 
METHODS 
Animals 
Eight adult Cebus monkeys, confirmed by epi physeal control of the 
appendicular skeleton with radiographic examination, were housed in 
individual cages in a room with stabilized temperature and humidity 
controls. Animals had been laboratory reared and shown to be negative 
with respect to tuberculosis. The monkeys were identifiable by a 
tatoo on the chest. Table 2 gives a breakdown of the animals in terms 
of age, weight, and sex which were the criteria used to divide them 
into two groups of four. The experimental group (Group 6) was chosen 
at random. 
Caged animals were transported to Houston for neutron activation 
bi -weekly. They were housed overnight on test days at 6aylor College 
of Medicine. After testing, animals were returned to the vivarium at 
Texas ARM University, College of Veterinary Medicine. 
Animal Diet 
Two months prior to the beginning of the experimental period, 
monkeys were changed from a commercial diet (Wayne Animal Diets, 
Chicago) to a modification of the diet as described by Corey and Hayes 
(86) . The only modification was a partial substitution of the sucrose 
with cornstarch (Argo Products Inc. , Argo, IL). 
18 
TABLE 2 
Monkey Background Data 
Controls 16A 33A 338 38 X S. D. 
Sex M F M F 
Age (months) 
Weight (kgs) 
92 71 46 50 65 21. 2 
3. 2 1. 8 2. 0 1. 8 2. 2 0. 7 
Experimentals 98 128 52A 36A X S. D. 
Sex 
Age (months) 
Weight (kgs) 
F F M M 
85 67 50 56 64. 5 15. 4 
1 7 2 3 2 2 2 0 2 1 0 5 
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The diet (Table 3) was mixed dry in 5 kg batches. The oil was 
mixed into the powder, followed by 4 1 of a hot 2. 5% agar-in-water 
solution. The slurry was then poured into a 20" x 36" fiberglass tray 
and stored at 4'C until feeding. The cake-like substance was cut into 
cubes of approximately 110 g and fed to the animals (one cube/animal) 
twice daily. Calcium from the mineral mix was calculated to be 0. 55$ 
of the dry diet. Because the casein contributes about the same amount 
of calcium to the diet, the total calcium percentage was 1. 1% of the 
dry diet. Each animal also received two orange slices and two raw 
peanuts per day. Distilled water was given ad libitum. 
Four experimental monkeys received sequentially an aqueous 
suspension of cortisone acetate (Upjohn) in daily intramuscular 
injections of 5 mg/kg b. w. (body weight) for four weeks, 10 mg/kg b. w. 
for three weeks, and 35 mg/kg b. w. for four weeks. This was followed 
by a five-week daily treatment with hydrocortisone succinate (Upjohn) 
(i. m. ) at 26 mg/kg b. w. Survivors (three monkeys) were slowly 
withdrawn from treatment by step-wise reduction of hydrocortisone over 
a period of 60 days after the experimental period. 
Neutron Activation 
~Heidi device. a est i ~ i g ppa t s as o t t d i 
plexiglass to assure better reproducibility of the animal positioning 
during irradiation and counting as depicted in Figures 2 and 3. 
Although the regional activation analysis involves a greater bone area 
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TABLE 3 
Synthetic Diet Composition 
Ingredients g/100 g of diet 
Casein 
Sucrose 
Cornstarch 
Cottonseed-soybean oil 
Yitamin mix 
Nineral mix 
Choline chloride 
Inositol 
Cellulose 
20. 0 
33. 4 
9. 1 
10. 0 
0. 5 
4. 0 
0. 3 
0. 1 
21. 6 
2l 
LEGS 
NEVT RON 
BEAM 
COPPER ST R~ P 
FIGURE 2 Sketch of monkey holder showing position of 
copper strips and neutron beam for leg irradiation. 
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FIGURE 3 Photograph of the monkey in holder for leg 
irradiation. Here shown with a plexiglass instead of a 
paraffin moderator. 
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(in this case the vertebral column or the lower extremities) than is 
the case with the Cameron single photon absorption technique (+5 mm x 
2 cm) (71), it is quite important to measure calcium changes in one 
area of bone with respect to time and not calcium differences between 
two adjacent areas of bone. The holder was placed in the same 
position over the irradiation port for consecutive irradiations by 
positioning marks on the port across from corresponding marks on the 
holder. This allowed the animal to maintain about the same body 
geometry from one sequence to the next. Nolded paraffin was built 
into the holder lateral to leg and spinal regions and a removable 
paraffin piece was placed above the given region during irradiations. 
This caused a better neutron flux uniformity throughout the irradiated 
region by thermalizing "fast" neutrons and reflecting others back 
towards the bone. Strips of copper were placed in both the spinal and 
appendicular regions of the holder (Figure 2) as a control for 
variations in positioning. In this manner, detectable amounts of Cu 
were created and could be counted simultaneously with Ca. 
Variations in corrected copper counts were then used to calculate the 
precision in positioning of the holder. There was no doubt also some 
minor variation in the positioning of the animals in the holder; yet, 
as each monkey was immobilized with 25 mg ketamine-HCI (Bristol Labs, 
Syracuse, NY) and subsequently strapped into the holder, this was kept 
to a minimum. 
Neutron source. The 3 mg Cf source at the Baylor College of 
Medicine was supplied by the Energy Research and Development 
Administration (ERDA). The source was small and had a relatively high 
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activity (approximately 4. 4 x 10 neutrons per second per Curie). 
produced a sufficient quantity of neutrons for low-density studies at 
short distances, and, according to Morgan et al. (87), 5 Cf is the 
preferred source for regional activation analysis in man. The source 
was shielded by a 7. 5 cm lead barrier in addition to 60 cm of 1. 0% 
water extended polyester (WEP) to minimize streaming. The irradiator, 
also constructed of WEP blocks, was built with an exit port of 20 cm x 
30 cm with a source to port distance of 41 cm. For the vertebral 
activation, a plexiglass collimator with a 20 cm x 10 cm exit port was 
employed (Figure 4). Monkeys were irradiated for 10 minutes for each 
region for a total of 20 minutes. The spinal region was activated and 
counted the first day, the leg region the following day, in order to 
make region to region interference negligible while counting. The 
same protocol was repeated for each test period. 
Countin facilit . Following the irradiation of an animal, it 
was removed immediately to the counting facility. Figure 5 is a block 
diagram showing the basic parts of the system and their commercial 
sources. This facility consisted of two opposing single crystal, 
sodium iodide detectors (Figure 6), each with three photomultipliers 
which were connected to a pre-amplifier, stabilizing amplifier, mixer- 
router, pulse-height analyzer and teletype. Monkeys remained in the 
above-mentioned holder for a 1000 second count in the supine position 
by placement of the holder between the detectors (dorsal and ventral 
to the monkey). The two photons in the range of 1. 10 to 3. 5 MeV were 
analyzed during this time by the multi-channel analyzer. After 
subtraction of background and correction for the contributions in this 
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FIGURE 4 Exit port (20 cm x 10 cm) with plexi gl ass 
collimator. 
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Mal (Th) Detectors (Bicron Corp. , Pre-amps 
Newbury, Ohio) (Ortec Inc. 
model 113) 
I 
Stabilizing 
amps 
8 
e 
A O 0 
XA 
m 0 
M 4 4 0 
X 0 
M 
mixer-router 
multi- 
channel 
pulse- 
height 
analyzer 
teletype 
The last three items in the block diagram were 
purchased together as one unit from Tracor 
Northern Co. 
FIGURE 5 Block diagram of counting facility. 
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FIGURE 6 Photograph of two opposing sodium iodide 
detectors. 
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area by Cl and Na (Figures 7 and 8), the number of Ca counts was 
computed. The relative contributions to the total counts in the area 
of 3. 10 NeV (4 Ca peak) had been previously determined with the use of 
phantoms (paraffin moulds in the geometry of monkey bones containing 
known amounts of the elements: sodium, chlorine and calcium). Thus, 
the "corrected calcium counts" shown in the results are directly 
proportional to grams of calcium. The purpose of this study, however, 
was not to determine absolute calcium values, but to test the 
precision of the method and the relative changes occuring in regions 
tested. For a following study, the authors wish to be able to express 
results in grams (Ca) after applying a cross-correction on the basis 
of the calcium ash content of the measured bones of the dead monkey 
(16A in Table 2, p. 18). 
Urine Collection 
A metabolism pan for the collection of urine was constructed of 
stainless steel and designed to fit beneath the monkey cages. The pan 
was designed with a locking urine collection cup beneath the drainage 
port. A wire screen was secured across the open face of the pan to 
prevent food and feces from entering the cup. A 24-hour urine 
collection was made from each animal periodically. Before removal of 
the cup at the end of this period, the pan surface was rinsed with a 
small quantity of distilled water. The washings were added to the 
collected urine and the total calcium per day was measured. Urine to 
be measured was first filtered with low-grade filter paper and samples 
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were stored at -25 C in labelled plastic vials. 
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FIGURE 7 Pulse-height of 24Na at various channel settings on PHA. 
(Calcium photopeak occurs between channels 205 and 234. ) 
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(Calcium photopeak occurs between channels 205 and 234. ) 
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Blood Collection 
Animals were bled from the femoral vein approximately every two 
weeks during the experiment . If assistance was available, the animals 
were bled unanesthetized; otherwise, the monkeys were given an 
intramuscular injection of ketamine-HC1 at 7 mg per kg body weight 
prior to bleeding. No anticoagulants were used. Serum was removed 
from the clot and stored at -25'C in labelled plastic vials. 
Bleedings always took place in the early afternoon in order to 
minimize the effects of daily biological rhythms . 
Biochemical Analyses 
Serum sodium, potassium and magnesium were determined on the 
Varian Techtron Model 1000 Spectrophotometer (Varian Ltd. , Melbourne). 
Serum and urinary calcium were performed by a similar technique at the 
NASA laboratories. Blood tests for Ht, Hb, RBC and WBC were performed 
at the Clinical Pathology Laboratory of the Texas A&M College of 
Veterinary Medicine using the microhematocrit, hemoglobin spectropho- 
tometer and Coulter Counter (Coulter Electronics, Hialeah, FL) 
methods. Serum cortisol was measured at the NASA labs according to 
the method of Foster and Dorm (88). 
Radiographic Examination 
As a comparison study, all animals were radiographed before and 
after the experimental period. Using a 300 ma X-ray machine (H. G. 
Fischer Inc. , Chicago, IL), radiographs were taken of the right stifle 
(mediolateral), as well as the lower vertebrae (lateromedial and 
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ventrodorsal). Films were taken at 52, 54 and 60 kV, respectively 
(1500 mAs). Kodak G Film with Finescreen (Kodak co. , Rochester, NY) 
was employed. An aluminum step-wedge was placed next to the bone for 
standardization. 
Pathological Examination 
Necropsies of monkeys which died during the experiment ( 16A and 
52A in Table 2, p. 18) were performed by the Department of Pathology 
of the Texas ASN College of Ueterinary Nedicine. Adrenal glands (see 
Results) of number 52A were fixed in 4X formalin and embedded in 
paraffin blocks . Nicrotome sections were stained with hemotoxyli n and 
eosin according to standard techniques (89) and examined by means of a 
microscope with a photographic attachment. 
Statistical Nethods 
Computation of X, S. D. , t tests and Wi 1 coxon matched-pairs 
signed-rank tests were performed on a Hewlett-Packard HP-11C 
programmable calculator. The t test for two means was according to 
Ostle (90) and the Wilcoxon test was performed as described by Siegel 
(91). Methods for the correction of calcium counts have been 
described earlier by Evans et al. (81). The sign test used for the 
evaluation of calcium count trends was also according to Siegel (91). 
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CHAPTER IV 
RESULTS 
Data reported here is a compilation of 11 bleedings, 11 
weighings, 22 neutron acti vati ons, and approximately 18 urinalyses per 
subject . Data was not separated into subgroupings such as male and 
female for evaluation due to the small number of subjects. 
Animal Height Changes 
The scale used to weigh the animals was a standard physicians 
model accurate to one-eight pound (0. 057 kg). Changes of 0. 10 kg or 
greater were assumed to be significant. Table 4 depicts the weight 
changes of all animals. Three out of four (75&) of the experimental 
animals lost weight, while none of the controls lost weight. Although 
there were no measurements made of muscle circumference in this study, 
muscle atrophy is a common side-effect of corticosteroid therapy (92) 
and may be responsible for weight losses. 
Routine Hematological Tests 
The routine hematological tests of hematocrit, hemoglobin, and 
red and white cell counts were included in the study (Table 5) as a 
check for extraneous factors such as anemia or leukocytosis associated 
with illness which might have influenced the outcome of the 
experiment. The variation expressed as coefficient of variation (C. V. 
equals the standard deviation in percentage) was the greatest for the 
leukocytes. One may calculate a t test value (90) by assuming that 
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TABLE 4 
Monkey Weight Chart 
Week 
Monkeys' weight (kg) 
33A 16A 38 98 36A 52A 128* 338 
-6 1. 8 3. 1 1. 9 1. 8 Z. O 2. 2 2. 3 2. 0 
1. 8 3. 2 1. 8 1. 8 2. 0 2. 1 2. 2 1. 9 
1. 8 3. 2 1. 8 1. 8 2. 0 2. 2 2. 3 1. 9 
1. 8 3. 4 1. 8 1. 7 2. 0 2. 1 2. 2 1. 9 
1. 8 3. 1 1. 9 1. 7 2. 0 2. 0 2. 2 1. 9 
1. 8 3. 1 1. 8 1. 7 2. 0 
1. 8 3. 2 1. 8 1. 7 2. 0 2. 0 
2. 2 1. 9 
2. 3 
1. 8 3. 2 1. 9 1. 7 2. 0 
1. 8 3. 3 --- 1. 7 2. 0 
1. 8 0 1. 8 1. 8 1. 9 
2. 1 
2. 0 
2. 4 1. 9 
2. 4 2. 0 
2. 5 
15 1. 8 1. 9 1. 8 2. 0 2. 5 2. 0 
Net 
change --- +0. 2 --- --- -0. 2 -0. 2 -0. 2 
* Experimental monkeys. 
g Died. 
Begin treatment = 0. 
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TABLE 5 
Routine Hematological Indices 
Animals Ht Hb R8C WBC 
Week (n) (5) (g/100 ml ) (x10~~/L) (x10"/L) 
Controls 
10 
15 
Average 15 
48. 8a2. 2 
49. 1+3. 0 
48. 2+2. 0 
51. 5+2. 4 
49. 4s2. 2 
15. 4+0. 9 
14. 212. 0 
14. 8s2. 2 
14. 0x1. 3 
14. 6+1. 5 
5. 8s0. 4 
5. 4+0. 6 
5. 6+0. 4 
5. 9+0. 3 
5. 7+0. 4 
8. 8+2. 5 
6. 9+2. 7 
5. 8a3. 6 
8. 4s3. 0 
7. 5+2. 6 
Experimental s 
10 
15 
Average 15 
46. 1s3. 3 
45. 0+3. 0 
53. 2+1. 1 
*51 5sZ 4 
50. 1+3. 2 
14. 5+2. 1 
15. 1~1. 1 
13. 9+1. 6 
15. 4+1. 2 
14. 7s1. 4 
5. 6xO. 3 
5. 2+0. 5 
5. 4'. 3 
5. 9s0. 4 
5. 5+0. 4 
7. 1+2. 6 
7. 022. 3 
6. 4+3. 2 
8. 0+2. 3 
7. 1+2. 2 
Total X 30 
C. V. 
50. 0+3. 0 14. 7i1. 5 
10% 
5. 6+0. 4 7. 3+1. 7 
23% 
*t, = (58. 2 - 50. 0)/(2. 1/2) = 7. 9. 
The deviation is significant for df = 7. 
the total mean approximates the expected mean for normal distribution 
according to the formula: t = (x; Xtota])/(s/N&). Using this 
computation, the value for week 15 of the hematocrit is outside the 
expected range. A mila polycythemia is reported to accompany dogs 
during hyperadrenocorticism in a small percentage of animals (93), 
which could explain the deviation. 
Serum Electrol tes 
As can be seen from Table 6, serum electrolytes displayed no 
alarming changes. Calcium, magnesium and potassium paired means (for 
each week) were compared by means of the t statistic. There was no 
significant difference between the control and the experimental groups 
(p & . 01). Because serum sodium was not measured for the experimental 
group in the week prior to the beginning of drug treatment, the paired 
test could not be applied. By applying the measurement for the 
comparison of two means, however, a t value could be computed. 
Comparing the total means for experimentals vs controls, the 
difference was insignificant (p & . 01) for sodium also. 
Patholo ical Examination 
One control animal died in the 13th week after a trip to and from 
Houston. The animal suffered from hyperthermia due to a malfunction 
of the air-conditioner in the van. Attempts to cool the animal were 
in vain. At necropsy, the pathologist found characteristic petechial 
hemorrhage in the heart and brain as well as acute degeneration of the 
heart, liver and kidneys. These findings are consistent with 
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TABLE 6 
Serum Electrolytes 
Animals Calcium Magnesium Sodium Potassium 
Week (n) (mg/100 ml ) (mg/100 ml ) (mmol e/1 ) (amIole/1 ) 
-1 7 
1 4 
3 4 
5 4 
9 4 
11 
16 6 
Average control 
9. 320. 8 
9. 1+0. 6 
10. 8+0. 3 
9. 5sO. 3 
9. 9+0. 4 
9. 4+0. 3 
9. 5+0. 3 
9. 6+0. 5 
Controls 
2. 5+0. 6 106+14 
3. 8+0. 7 1Z6+ 2 
3. 8+0. 7 129+ 4 
2. 6g0. 3 138+ 3 
3. 3+0. 5 136+18 
2. 5+0. 1 135+ 3 
2. 1+0. 2 1372 4 
2. 9+0. 6 130+ 9 
Experimentals 
3. 1+0. 3 
3. 3+0. 2 
3. 0+0. 2 
2. 8+0. 4 
3. 8+0. 5 
3. 3+0. 2 
4. 8+0. 9 
3. 4s0. 6 
-1 4 
1 4 
3 4 
5 4 
9 4 
11 3 
16 5 
Average exper. 
t values 
df 
9. 8+0. 6 
9. 1+0. 2 
9. 9+1. 0 
9. 5s0. 3 
9. 6+Q. 4 
8. 9+0. 7 
9. 5+0. 6 
9. 5+0. 6 
1. 0 
2. 4+0. 2 
3. 7+0. 2 
3. 1~0. 1 
2. 7+0. 4 
2. 7+Q. 5 
3. 0e0. 5 
2. 3+0. 4 
2. 8+0. 4 
0. 7 
123s14 
131+ 4 
142+ 6 
138+ 2 
138m 4 
134+ 5 
134m 7 
*0. 9 
3. 5+0. 4 
3. 8+0. 5 
2. 6s0. 3 
3. 0+0. 1 
3. 0+0. 2 
3. 3+0. 9 
4. 9+1. l. 
3. 4+0. 7 
*t value for a comparison of two means. Begin treatment on week 1. 
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cardi ovascul ar cri si s after hyperthermi a. An experimental monkey 
suffered an acute onset of illness just prior to death in the 15th 
week of the experiment. The only abnormality described at necropsy 
was a severe atrophy of the adrenal glands, characterized by a 
diminished size and fatty infiltration (Figure 9). It is probable 
that this animal died from an Addisonian crisis (92) of adrenal 
insufficiency in spite of the daily cortisol injections given. Focal 
skin pigmentation, a frequent symptom of hyperadrenocorti ci sm (93), 
was also noted. 
Radio ra h Examination 
No differences in bone density could be determined by examination 
of radiographs taken just prior to and at the end of the experimental 
period. Figures I (p. 11) and 10 are reproductions of, respectively, 
BEFORE and AFTER radiographs made for an experimental monkey. 
Contrast duplication of the aluminum step-wedge was difficult, a fact 
which further substantiates the problems involved when one attempts to 
visually evaluate small bone density differences by means of 
radiographs with a step-wedge. 
Bone Calcium Measurement with PBNAA 
The bone calcium values for both the leg and spine regions are 
reported as corrected counts and as a percentage change for each 
animal's total mean (Tables 7-16). These changes were assumed to be 
due to random errors in positioning and counting geometry. This 
assumption was partially confirmed bythe fact that calcium counts 
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(40x) 
(100x) 
FIGURE 9 Adrenal gland in paraffin section (H. E. ) showing fatty 
infiltration and local atrophy at 40x and 100x in microphotographs. 
~ ~ ~ ~ ~ ~ ~ ~ ~ ~ I 
~ ~ ~ 
~ ~ ~ ~ ~ ~ ~ ~ 
~ ~ 
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TABLE 7 
Experimentals — Spine position 
Normalized Calcium 
Monkey and percent change 
Week 98 (5) 128 (%) 36A (%) 52A (V) 
-6 15976 + 4. 3 
-4 14873 - 2. 8 
-2 14780 - 3. 5 
*0 15653 + 2. 3 
2 15107 - 1. 2 
4 15541 + 1. 6 
6 14924 — 2. 5 
9 14692 - 4. 1 
11 15188 - 0. 7 
13 15778 + 3. 1 
15 15730 + 2. 8 
C. V. = 3. 0% 
18530 - 1. 6 
19197 + 1. 9 
14959 + 0. 9 
14590 - 1. 6 
15190 - 3. 3 
15124 - 0. 8 
18480 - 1. 9 
18591 - 1. 3 
18040 - 4. 4 
18535 - 1. 6 
15186 + 2. 4 15799 + 3. 7 
14589 - 1. 6 
14660 — 1. 1 
15021 - 1. 4 
14098 - 7. 5 
14876 + 0. 3 15579 + 2. 2 
18960 + 0. 7 15935 + 7. 4 
18982 + 0. 8 
19581 + 3. 8 
19483 + 3. 4 
C. V. = 2. 5% 
14444 - 2. 6 
14998 + 1. 1 
14053 - 5. 3 
C. V. = 3. 2X 
14841 - 2. 6 
15927 + 4. 5 
C. V. = 3. 7% 
18763 - 0. 4 14828 — 1. 6 15586 + 0. 8 
*Begins experimental period. 
TABLE 8 
Controls - Spine Position 
Normalized Calcium 
Monkey and percent change 
Week 38 (%) 33A (4) 16A (%) 338 (%) 
-6 14847 - 1. 9 
-4 14987 - 1. 0 
-2 15194 + 0. 4 
*0 15033 — 0. 6 
2 14674 - 3. 0 
4 15625 + 3. 3 
6 14738 — 2. 6 
9 15145 + 0. 1 
11 15419 + 1. 9 
13 15658 + 3. 5 
15 
C. V. = 2. 2% 
13788 - 5. 8 21410 + 2. 1 
14725 + 0. 5 20797 - 0. 8 
14171 - 5. 1 
15126 + 1. 3 
15063 + 2. 8 
14518 - 0. 9 
15043 + 2. 7 
14824 + 1. 2 
21461 + 2. 4 
21638 + 3. 2 
20785 - 0. 8 
20299 - 3. 2 
14791 - 0. 9 
14849 - 0. 5 
14063 - 5. 8 
15364 + 2. 9 
14815 + 1. 2 21214 + 1. 2 15037 + 0. 7 
14112 - 3. 6 
14476 - 1. 1 
14695 + 0. 3 
C. V. = 2. 8X 
20061 - 4. 3 
C. V. = 2. 5% 
13888 + 7. 0 
15855 + 6. 2 
15991 + 7. 1 
C. V. = 3. 7X 
15039 + 2. 7 20993 + 0. 1 15086 + 1. 0 
*Begins experimental period. 
TABLE 9 
Monkey 52A - Leg Position 
No. of 
weeks l Change Normalized Ca Normalized Cu 
-2 
13 
+ 0. 9 
+ 2. 0 
- 1. 6 
+ 1. 7 
+ 5. 0 
+ 0. 5 
- 2. 9 
- 1. 9 
- 0. 2 
31069 
31417 
30292 
31337 
32342 
30969 
29892 
30201 
30726 
29769 
C. V. = 2. 5% 
459299 
453164 
443026 
457161 
450529 
435430 
439169 
443946 
C. V. = 3. 7% 
Correlation (r = 0. 69). 
*Begins experimental period. 
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TABLE 10 
Monkey 36A - Leg Position 
No. of 
weeks I Change Normalized Ca Normalized Cu+ 
-4 
13 
15 
- 4. 2 
+ 1. 9 
+ Z. O 
- 0. 1 
- 1. 0 
+ 5. 9 
+ 0. 1 
- 5. 1 
+ 0. 7 
- 3. 2 
28438 
30262 
30288 
Z9673 
30198 
29398 
31460 
30091 
28187 
29898 
28757 
C. V. = 4. 0% 
450859 
448830 
461941 
461565 
452260 
454033 
468671 
470711 
444563 
438735 
446043 
C. V. = 2. 2% 
Correlation (r = 0. 42). 
*Begins experimental period. 
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TABLE 11 
Nonkey 12B - Leg Position 
No. of 
weeks B Change Normalized Ca++ Normalized Cu++ 
-6 
*0 
13 
15 
- 0. 8 
- 2. 4 
+ 1. 2 
+ 0. 4 
+ 1. 7 
- 1. 4 
- 3. 3 
+ 0. 4 
- 1. 6 
+ 1. 5 
+ 4. 3 
40343 
39695 
41147 
40828 
41364 
40099 
39330 
40851 
40023 
41283 
42434 
C. V. = 2. 1% 
474201 
474970 
497989 
474314 
492089 
480899 
464969 
473846 
462746 
477924 
477924 
C. V. = 2. 2% 
Correlation (r = 0. 52). 
*Begins experimental period. 
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TABLE 12 
Monkey 98 - Leg Position 
No. of 
weeks f. Change Normalized Ca++ Normalized Cu++ 
-6 
-2 
*0 
13 
15 
+ 9. 0 
+ 1. 8 
+ 8. 9 
- 0. 2 
+ 1. 7 
- 3. 4 
- 3. 0 
- 1. 2 
- 5. 1 
- 2. 0 
- 6. 5 
32267 
30156 
32244 
29560 
30110 
28598 
28723 
29252 
28085 
29015 
27681 
C. V. = 5. 1% 
467231 
438760 
443051 
460440 
465281 
437104 
453583 
453026 
447879 
434296 
447172 
C. V. = 2. 51 
Correlation (r = 0. 33). 
*Begins experimental period. 
TABLE 13 
Monkey 38 - Leg Position 
No. of 
weeks V, Change Normalized Ca++ Normalized Cu~ 
-2 
*0 
13 
15 
+ 5. 2 
+ 2. 5 
— 0. 2 
- 0. 3 
+ 1. 0 
+ 2. 6 
- 1. 8 
- 5. 8 
- 2. 4 
- 3. 9 
+ 3. 0 
30708 
29897 
29124 
29081 
29495 
29955 
28666 
27486 
28481 
28029 
30062 
C. V. = 3. 3X 
482723 
456754 
440978 
444408 
450431 
446922 
439224 
437265 
432854 
435687 
447939 
C. V. = 3. 2% 
Correlation (r = 0. 81). 
Begins experimental period. 
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TABLE 14 
Monkey 338 - Leg Position 
No. of 
weeks % Change Normalized Ca++ Normalized Cu++ 
*0 
13 
15 
- 6. 3 
- 1. 3 
+ 3. 5 
- 0. 0 
- 3. 1 
+ 0. 4 
- 1. 4 
+ 0. 9 
+ 1. 8 
+ 2. 6 
+ 2. 9 
28551 
30066 
31544 
30469 
29538 
30617 
30053 
30754 
31021 
31261 
31364 
C. V. = 2. 8% 
428141 
447086 
467293 
441865 
495086 
450788 
467252 
449534 
452966 
446043 
C. V. = 4. 0'X 
Correlation (r = 0. 47). 
*Begins experimental period. 
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TABLE 15 
Nonkey 16A - Leg Position 
No. of 
weeks N Change Normalized Ca Normalized Cu++ 
+ 0. 4 
+ 0. 2 
+ 1. 7 
+ 3. 5 
+ 1. 7 
- 2. 6 
+ 0. 4 
— 8. 6 
+ 3. 2 
Correlation (r = 0. 35). 
45127 
45066 
45728 
46540 
45728 
43794 
45132 
41107 
46404 
C. V. = 3. 9% 
478540 
476511 
483238 
485413 
454033 
480093 
481526 
490089 
C. V. = 2. 3% 
*Control animal received no treatment in experiment period. 
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TABLE 16 
Monkey 33A - Leg Position 
No. of 
weeks X Change Normalized Ca++ Normalized Cu 
-4 
*0 
13 
15 
— 4. 2 
+ 1. 9 
+ 2. 0 
— 0. 1 
+ 1. 7 
- 1. 0 
+ 5. 9 
+ 0. 1 
- 5. 1 
+ 0. 7 
- 3. 2 
28438 
30262 
30288 
29673 
30198 
29398 
31460 
30091 
28187 
29898 
28757 
C. V. = 3. 3% 
433712 
435143 
447609 
444195 
438277 
450029 
456025 
445518 
437874 
443102 
C. V. = 1. 6% 
Correlation (r = 0. 49). 
*Control animal received no treatment in experiment period. 
51 
from legs (x) and copper counts from the strip placed in the holder 
(y) (see METHODS) had a positive correlation for all eight animals 
when tested by linear regression. The correlation coefficients ranged 
from (r =) 0. 33 to 0. 81. For calcium counts, the mean standard 
deviation when expressed in percentage (coefficient of variation 
C. V. ) was 3. 2% for controls versus 3. 3% for experimentals. The 
calcium count C. V. for the leg region was higher (3. 4X) than that for 
the spinal region (3. 1%) for all measurements as a whole. The total 
C. V. for both regions was 3. 25%. 
To test for significant changes in either of the groups during 
the corticosteroid therapy, the sign test was done on the last five 
measurements for both regions. If bone losses were to occur in this 
period, one can expect a distribution of +!- changes (from X) 
significant (p ( . 01) from a (p = 0. 5) distribution. This was not the 
case for either group. Only experimental monkey 98 showed an 
unexpected negative trend from X during the last measurements (p = 
. 016 for n = 6), however, this trend was not to be repeated for the 
same animal in the spinal region. Bone losses occurring in only one 
animal in one area seems unlikely. At any rate, the leg region of 98 
showed the poorest correlation (r = 0. 33) between calcium and copper 
values which argues for the fact that positioning was not the major 
factor causing the large C. Y. (= 5. 1%). 
Serum Cortisol Chan es 
In Table 17 and Figure 11, the means and standard deviations for 
the serum cortisol values are depicted. Although there was a large 
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TABLE 17 
Monkey Serum Cortisol 
No. of 
weeks 
Control s 
X S. D. 
Experimentals 
X S. D. Value 30 min p. i. 
15 
121 + 58 
97 s 70 
115 + 46 
68 1 22 
76 s 28 
229 + 227 
88 + 37 
114 + 47 
153 R 87 
60 + 17 
157 + 47 
148 + 76 
130 + 33 
360 + 142 
81 i 25 
140 s 73 
800 
All values are expressed in ug/100 ml. 
t test: Average difference = 154; S. D. difference = 91; t = 4. 8; 
df = 7. 
*This was a serum cortisol value from a blood sample taken +30 min 
after a subcutaneous injection of cortisol at a dose of 26 ug/kg b. w. 
This value was not used in the calculation of means. 
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FIGURE 11 Serum cortisol values as means vs time. (15h p. i. ) 
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intra-measurement var1ation, it was evident that the daily corti- 
sone/cortisol injections had a positive effect (p & . 05) on the 
experimental group when either the paired t test or the Wilcoxon 
matched-pairs signed-rank test were employed. Urinary cortisol values 
were measured, but are not included in the results due to the fact 
that the S. D. often exceeded the mean for groups measured. The author 
assumes that 1nterfering components in the urine were too variable in 
concentration (dependent not only upon the animal's concentrating 
ability, but also upon the amounts of distilled water used to rinse 
the metabolism pans--see NETHDDS) to use the very sensitive 
radioimmunoassay for serum as a method for measuring urine cortisol. 
Urinar Calcium Excretion 
Because the spectrophotometric measurement of calcium is less 
sensitive to interferences than the RIA (radioimmunoassay), variations 
in total calcium in the urine/24 hours were acceptable. As depicted 
in Table 18, ur1nary calc1um in the experimentals was slightly 
elevated. 
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TABLE 18 
Monkey Urinary Calcium 
No. of 
weeks 
Controls 
X S. D. 
Experimentals 
n X S. D. 
-2 
12 
15 
10 
10 
. 084 + . 06 
. 14 + . 07 
. 09 + . 05 
. 12 x . 08 
. 11 + . 05 
. 10 + . 04 
. 35 + . 18 
. 26 + . 22 
10 
12 
. 11 + . 05 
. 13 + . 07 
. 13 + . 06 
. 21 + . 29 
. 10 e . 03 
. 34 + . 70 
. 39 + . 27 
. 27 I . 12 
All values are expressed in mg/24 hours. 
Average of differences = . 05; S. D. of difference = . 08; t = 1. 8; df 
— 7 
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
Osteoporosis, as a side-effect of long-term glucocorticosteroid 
therapy in humans, often takes years to develop (53). On the other 
hand, in experimental studies in rabbits, bone loss occurred following 
several weeks of glucocorticosteroid therapy (47). 14oreover, in 
mature rats, there has been no negative effect on bone as a result of 
similar therapies (49). Where the monkey should be placed within this 
range of possibilities is as yet unsolved. In the only other study 
reported in which bone parameters were examined in monkeys during a 
corticosteroid insult, the effects were insignificent (51). These 
authors administered deflazacort, an oxazoline derivative of predni- 
solone, to both juvenile and mature cynomolgus monkeys during a one 
year period. In this previous study, no dose-dependent changes were 
found for the following parameters: plasma calcium, phosphate, 
alkaline phosphatase, 25-hydroxy-vitamin D and urinary calcium 
excretion. Neither did bone volume, bone circumference nor bone cell 
counts have changes. These reports coincide with the results of the 
present study in Cebus monkeys. However, before drawing conclusions 
concerning the susceptibility of monkeys to the effects of 
glucocorticosteroids on bone, the following should be considered. 
Firstly, deflazacort has been shown to have remarkably few 
effects on bone when compared to other corticosteroids. LoCasci o et 
al. (94) compared patient groups who received either prednisolone or 
deflazacort. Iliac crest biopses were examined before and after a 
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six-month treatment period for both groups. Bone biopsies had a 
significant reduction in the total bone volume (TBY) in the 
prednisolone group (n = 13), whereas, the changes for the deflazacort- 
treated group were insignificant (n = 14). Lund et al. (58) in 
Denmark also showed deflazacort to cause less calcium release than 
prednisolone in vitro. 
In the present study, the length of the treatment period may have 
been a decisive factor in the absence of calcium changes. Elevated 
serum cortisol, adrenal glands showi ng atrophy at post-mortem 
examination, weight losses and f'ocal hyperpigmentation of the skin 
suggest that the dosage of glucocorticosteroids, as given, had a 
measurable effect on the endocrinological homeostasis, but evidently 
not on bone metabolism. This could be solely due to the length of the 
treatment period if one compares the results to those of Nagant de 
Deuxchaisnes and Devogelaar (95). If the young adult Cebus in this 
study had lost bone calcium at the same rate as the young adult men in 
the experiment by Nagant de Deuxchaisnes (1. 71 - 2. 26%%d/year in the 
radius), the mineral loss would not have been detected in a 16-week 
experiment (2. 26 x ( 16/52) = 0. 69&) which lay under the detection 
range in this experiment with eight animals. An ideal but expensive 
study would be to examine regional calcium changes in larger groups of 
Cebus monkeys for a longer period, while comparing several different 
glucocorticosteroid compounds with each other. 
A third factor which may have played a role in the results of the 
above-mentioned experiments with monkeys is the CBG (cortisol binding 
globulin) interaction with the drug used. Assandri et al. (96) have 
shown that deflazacort inhibits or prevents CBG plasma binding to 
itself in man, rats, dogs and cynomolgus monkeys, which tends to 
reduce its biological effect. The present author suggests that there 
is a positive correlation between the CBG binding to a particular 
glucocorticosteroid and the effect of this corticosteroid on bone. 
This would also explain differences seen in the effects of cortisone 
on man and Cebus monkeys. According to Seal and Doe (97), the latter 
is only able to bind a small percentage of cortisol with CBG (3. 3 
ug/100 ml as compared to 22 ug/100 ml in man). If this hypothesis is 
true, one would expect to find the same response in squirrel (Saimiri 
s i dsI d h i Ihi tt yt i 1 i t I keys s nss nese ked in th 
Cebus due to the relatively low CBG binding of cortisol in these two 
species (5. 0 ug/100 ml and 1. 4 ug/100 ml, respectively). Furthermore, 
an interesting fact is that estrogen also binds to CBG (98). After 
menopause, it is logical that there would be more CBG available to 
bind to cortisol, a fact which may yet help to explain why post- 
menopausal women lose bone at much higher rates than men (2). 
Lastly, concerning the in vivo regional activation analysis of 
the Cebus monkey, the results were similar to those in the literature 
cited by Mazess et al. (83). The Cebus monkey proved itself a 
suitable animal in terms of size, manageability and feasibility for 
regional calcium measurements. 
59 
REFERENCES 
McBean, L. D. , and E. W. Speckmann. 1974. A recognition of the 
interrelationships of calcium with various dietary components. 
Am. J. Clin. Nutr. 27:603. 
Riggs, B. L. , H. W. Wahner, W. G. Dorm, R. B. Mazess, and K. P. 
Dfford. 1981. Differential changes in bone mineral density of 
the appendicular and axial skeleton with aging. J. Clin. Invest. 
67:328. 
Cohn, S. H. , A. Vaswani, I. Zanzi, and K. J. Ellis. 1976. Effect 
of aging on bone mass in adult women. Am. J. ~Ph siol. 230:143. 
Semb, H. 1966. Experimental disuse osteoporosis. Acta Soc. 
Med. ~Us. 71:98. 
Fleisch, H. , R. G. G. Russell, B. Simpson, and R. C. Muhlbauer. 
1969. Prevention by diphosphonate of immobilization osteoporosis 
in rats. Nature 223:211. 
Griffith, A. P. 1971. Immobilization hypercalciuria: treatment 
a d a p ssihie pathophysioiogic eche is . ~heros ac M d. ag: 
1322. 
Rambaut, P. D. , M. Smith, P. Mack, and F. S. Vogel. 1975. 
Biomedical results of Apollo. NASA 
~Re ort Wash. , DC. 
Douglass, W. R. 1970. The calcium metabolism problem in space 
medical science. 
~S ace Life Sci. 2:151. 
Griffith, H. J. , R. Hunt, R. ZiaInera, H. Finberg, and J. Cutting. 
1975. Role of calcium and fluoride in osteoporosis in rhesus 
monkeys. Invest. Radiol. 10:263. 
10. Anderson, M. P. 1977. Long-term effect of low dietary calcium to 
phosphorus ration on the skeleton of the Cebus albifrons. J. 
Nutr. 107:834. 
11. Murray, R. D. 1960. Radiological bone changes in Cushing's 
syndrome and steroid therapy. Brit. J. Radiol. 33: 1. 
12. Kemple, K. L. , and M. N. Mueller. 1975. Corticosteroid therapy in 
rheumatoid arthritis. Clin. Res. 23:324. 
13. Cohn, S. H. , K. J. Ellis, A. Martino, and S. Asad. 1976. Loss of 
calcium from axial and appendicular skeleton in patients with 
chronic renal failure. Calcif. Tiss. Res. 21:216. 
14. Nordin, B. E. C. 1973. Metabolic Bone and Stone Disease. Chur- 
chill-Livingstone, London. 
60 
15. Riggs, B. L. , R. V. Randall, H. W. Wahner, J. Jowsey, P. J. Kelly, 
and M. Singh. 1972. The nature of metabolic bone disorder in 
acromegaly. J. Clin. Endocr. Metab. 34:911. 
16. Seville, P. D. 1973. Osteoporosis, a review. In Clinical As- 
ects of Metabolic Bone Disease, B. Frame, A. Parfitt and H. 
Duncan (eds. . Excerpta Ned. , Amsterdam. 
17. Ibbotson, K. J. , S. M. D'Souza, J. A. Kanis, D. L. Douglas, and 
R. G. G. Russell. 1980. Physiological and pharmacological regula- 
tion of bone resorption. Netab. Bone Dis. and Rel. Res. 2: 177. 
18. Leach, C. S. , P. C. Johnson, and P. C. Rambaut. 1976. Netabolic 
and endocrine studies-2nd manned space lab mission. Aviat. 
~S ace 
Environ. Ned. 47:402. 
19. Rambaut, P. C. , and R. S. Johnston. 1979. Prolonged weightless- 
ness and calcium loss in man. Acta Astron. 6: 1113. 
20. Hansen, C. A. , H. Duncan, and A. Curtiss. 1970. Corticosteroid 
induced osteoporosis in rabbits. Clin. Res. 18:455. 
21. Mitruka, B. N. , and H. M. Raunsly. 1976. Animals for Nedical 
Research Models for the Stud of Human Disease. J. Wi ey and 
Sons, New Yor . 
22. Peppier, W. W. , and R. B. Mazess. 1981. Total body bone mineral 
and lean body mass by dual photon absorptiometry. I. Theory and 
measurement procedure. Calcif. Tiss. Int. 33:353. 
23. Jubb, K. V. , and P. C. Kennedy. 1970. Patholo of Domestic Ani- 
mals. Vol. 1, 2nd ed. Academic Press, New York. 
24. Stauffer, M. , D. Baylink, and J. Wergedal. 1973. Decreased bone 
formation, mineralization and enhanced resorption in calcium 
deficient rats. Am. J. ~Ph siol. 225:269. 
25. Goulding, A. 1980. Effects of dietary supplement on parathyroid 
function, bone turnover and bone composition in rats taking 
restricted amounts of calcium. Min. Electr. Metab. 4:203. 
26. Orny, A. , I. Wolinsky, and K. Guggenheim. 1974. Structure of 
long bones of rats and mice fed a low-calcium diet. Calcif. 
Tiss. Res. 15:71. 
27. Dudl, R. J. , J. W. Ensink, and J. W. Baylink. 1973. Evaluation of 
intravenous calcium as therapy for osteoporosis. Am. J. Ned. 
55:631. 
28. Bollet, A. J. 1968. Osteoporosis or the osteoporosities. Am. J. 
Med. Sci. 256:271. 
61 
29. Fleisch, H. , R. G. G. Russell, B. Simpson, and R. C. Nuhlbauer. 
1969. Prevention by diphosphonate of immobilization osteoporosis 
in rats. Nature 223:211. 
30. Wranski, T. J. , and E. R. Morey. 1982. Skeletal abnormalities in 
rats induced by simulated weightlessness. Metab. Bone Dis. and 
Rel. Res. 4:69. 
31. Semb, H. 1966. Experimental disuse osteoporosis. Acta Soc. 
Ned. 
~U s. 71:98. 
32. Geiser, M. , and J. Trueta. 1958. Nuscle action, bone rarefac- 
tion and bone formation. J. Bone J. ~5ur . 408:282. 
33. Allison, N. , and B. Brooks. 1921. Bone atrophy. An experi- 
mental and clinical study of changes in bone which result from 
non-use. Surcu. 
~G n. Dbstet. 33:250. 
34. Burkhar, J. M. , and J. Jowsey. 1967. Parathyroid and thyroid 
hormones in the development of immobilization osteoporosis. 
~edo I ol 01:1053. 
35. Semb, H. 1966. The chemical composition of microscopic cortical 
bone structures from immobilized dogs. Acta Soc. Med. 
~U s. 71:197. 
36. Landry, M. , and H. Fleisch. 1964. The influence of immobili- 
zation on bone formation as evaluated by osseous incorporation of 
tetracyclines. J. Bone J. ~Sur . 46B:764. 
37. Mack, P. B. , R. A. Hoffman, and A. Al-Shawi. 1968. Physiologic 
and metabolic changes in Macaca nemestrina on two types of diets 
during restraint and non-restraint: II. Bone density changes. 
~he s ce Med. 39:104. 
38. Mack, P. B. 1971. Bone density changes in a Macaca nemestrina 
one 3 do ine th einsatellite III 9 oye t. ~Ae s a e Med. 
42:828. 
39. Urist, N. R. , and J. Adams. 1969. Bone dynamics. J. Bone J. 
~Sur . 544:1120. 
40. Mack, P. B. , and F. B. Vogt. 1970. Skeletal density measurements 
during Apollo VII and VIII missions. Report of Texas Women' s 
University to NASA Nanned Spaceflight Center Contr. 9-8888. 
41. Douglas, W. R. 1970. The calcium metabolism problem in space 
medical science. 
~S ace Life Sci. 2:151. 
62 
42. Portugalov, V. V. , E. Savina, and A. S. Koplansky. 1976. Effect 
of spaceflight factor on the masmal. Aviat. 
~S ace Environ. Ned. 47:813. 
43. Urist, M. R. 1958. The problem of osteoporosis. Clin. Res. 
6:377. 
44. Jaffe, N. L. , and N. Epstein. 1972. The effect of cortisone on 
femoral and humoral heads in rabbits. C'lin. ~Ortho . 82:221. 
45. Thompson, J. S. , R. Palmieri, R. Crawford, and A. Elial. 1972. 
The effect of porcine calcitonin on osteoporosis induced by 
adrenal cortical steroids. J. Bone J . ~Sur . 54A: 1120. 
46. Freehafer, A. A. 1969. Effect of hydrocortisone and gonadal 
hormones on growing rabbit bone. J. ~Sur . Res. 9:35. 
47. Adams, P. , and J. Jowsey. 1967. Effect of calcium on cortisone 
i d c d osteoao osis i abbits. ~ddo i oio 81:tsd. 
48. Hansen, L. A. , H. Duncan, and A. Curtiss. 1970. Corticosteroid 
induced osteoporosis in rabbits. Clin. ' Res. 18:455. 
49. Yasamura, S. , K. J. Ellis, and S. H. Cohn. 1976. Effect of 
hydrocortisone on total body calcium in rats. J. Lab. Clin. Ned. 
68:834. 
50. Follis, R. H. 1951. The effect of cortisone on the growing bones 
of rats. Proc. Soc. ~Ex . Biol. Ned. 76:722. 
51. Beneton, N. , L. Harvey, D. Guilland-Cumming, B. Imbimbo, R. G. G 
Russell, and J. A. Kanis. 1982. Effects of deflazacort on 
skeletal metabolism in cynomolgus monkeys. Calcif. Tiss. Int. 
~Su l. 34:63. 
52. Cushing, H. 1932. The basophil adenomas of the pituitary body 
and their clinical manifestations. Bull. Johns 
~Ho kins ~Hos 
50:137. 
53. Pietrogrande, V. , and P. Nastromarino. 1957. Dsteopatia da 
prolongato trattamento cortisonico. ~0rto . Traum. 25:791. 
54. Murray, R. D. 1960. Radiological bone changes in Cushing's 
syndrome and steroid therapy. Brit. J. Radiol. 33: l. 
55. Meunier, P. J. , P. Courpron, C. Edouard, and J. Bernard. 1973 
Physiological senile evolution and pathological rarefaction of 
bone, quantitative and comparative histological data. Clin. 
Endocr. Metab. 2:239. 
63 
56. Bressot, C. , P. J. Meunier, i4. C. Chapuy, E. Lejeune, C. Edouard, 
and A. J. Darby. 1979. Histomorphometric profile, pathophysi- 
ology and reversibility of corticosteroid-induced osteoporosis. 
Metab. Bone Dis. Rel. Res. 1:303. 
57. Bernini, P. Nardi, and L. Fusi. 1982. Plasma levels of 
calcitonin in glucocorticoid treated patients. Calcif. Tiss. 
Int. ~Su l. 34:69. 
SII. Lund, G. , J. G P d so . d C. Egs ud. Iggt. I ~Proceedin s of 
the 1st International Collo uium on Glucocorticoid Effects. Un- 
iver. Sienna, Italy. 
59. Russell, J. E. , and L. V. Avioli. 1982. Effect of prednisone, 
deflazacort and the 1-6485 component on glycolytic activity in a 
growing animal. Calcif. Tiss. Int. ~Su l. 34:22. 
60. Chen, T. L. , and S. Feldman. 1979. Glucocorticoid receptors and 
actions in subpopulations of cultured rat bone cells. Mechanism 
of dexamethasone potentiation of parathyroid hormone-stimulated 
cyclic AMP. J. Clin. Invest. 63:750. 
61. Teitelbaum, S. L. 1982. Effects of glucocorticoids on osteo- 
lysis. Cal ci f. Tiss. Int. ~Su l. 34: 10. 
62. Raisz, L. G. , and Y. S. Chyun. 1982. Inhibition of bone growth in 
vitro by cortisol and its reversal by prostaglandin E2. Calcif. 
Tiss. Int. 
~Su l. 34:62. 
63. Kovarik, J. , and W. Kuster. 1981. Clinical relevance of 
radiological examination and bone density measurement in 
osteoporosis of old age. Skelet. Radiol. 7:37. 
64. Jowsey, J. , and B. L. Riggs. 1972. Assessment of bone turnover 
by microradiography and autoradiography. Semin. Muci. Ned. 2:3. 
65. Cameron, J. R. , and S. Sorenson. 1963. Measurement of bone 
mineral in vivo: an improved method. Science 142:230. 
66. Wilson, C. R. 1972. Abstract of doctoral thesis, University of 
Wisconsin. Nadison, Wisconsin. 
67. Chalmers, J. , and J. K. Weaver. 1966. Cancellous bone and its 
strength and changes with ageing and an evaluation of some 
methods for measuring its mineral content. J. Bone J. ~Sur . 
48A:299. 
68. Nazess, R. B. , N. Ort, P. Judy, and W. Nether. 1970. Absorptio- 
et ic Oon nin I dete I etio usi g "'Gd. In ~p o eedi s of 
Bone Measurement Conference, J. P. Cameron (ed. ). U. S. AEC 
700515:308, Wash. , D. C. 
64 
69. Wilson, C. R. , and M. Madsen. 1977. Dichromatic absorptiometry 
of vertebral bone content. Invest. Radiol. 12:180. 
70. Mazess, R. B. 1971. Estimation of bone and skeletal weight by 
direct photon absorptiometry. Invest. Radial. 6:52. 
71. uestions and answers about bone mineral anal sis. 1977. Bull- 
etin. Norland Instruments. Ft. Atkinson, Wisconsin. 
72. Mazess, R. B. , W. W. Peppier, C. H. Chestnut, W. B. Nelp, S. H. Cohn, 
and I. Zanzi. 1981. Total body bone mineral and lean body mass 
by DPA. Comparison with total body calcium by neutron activa- 
tion. Calcif. Tiss. Int. 33:361-364. 
73. Cohn, S. H. , and C. S. Dombrowski. 1971. Measurement of total 
body Ca, Na, Cl, N, and P in man by in vivo neutron activation 
analysis. J. Nucl. Med. 12:499. 
74. Palmer, H. E. , W. E. Nelp, R. Murano, and C. Rich. 1968. The 
feasibility of in vivo neutron activation analysis of total body 
calcium and other elements of body composition. ~Ph s. Med. Biol. 
13:269. 
75. Williams, E. D. , K. Boddy, and J. J. Brown. 1982. Whole body 
elemental composition in patients with hypertension. Eur. J. 
Clin. Invest. 12:321. 
76. Chamberlain, M. J. , J. H. Fremlin, and D. K Peter. 1968. Total 
body Ca by whole body neutron activation. Brit. J. Med. 2:581. 
77. Kennedy, N. S. , and R. Estell. 1982. Total body neutron 
activation analysis of calcium: calibration and normalisation. 
~Ph s. Med. Biol. 27:697. 
78. Harrison, J. E. 1979. Bone mineral measurements of the central 
skeleton by neutron activation analysis for routine investigation 
of oateoporia. ~Radi to la: Zr 
79. Maziere, B. , D. Kuntz, and D. Camor. 1979. In vivo analysis of 
bone Ca by local activation of the hand. J. Nucl. Med. 20:85. 
80. Kuntz, D. , Maziere, B. , and Knipper, M. 1981. Analyse in viva 
du calcium osseux par activation neutronique localisee de la main 
chez I'osteoporotique. Revue Du Rhum 48:487. 
81. Evans, H. J. , A. D. LeBlanc, and P. C. Johnson. 1976. Feasibility 
study. In vivg neutron activation for regional measurement of 
calcium using Cf. Med. ~Ph s. 3: 148. 
82. Evans, H. J. and A. LeBlanc. Unpublished data. 
65 
83. Mazess, R. B. , W. W. Peppier, C. H. Chestnut, W. B. Nelp, S. H. Cohn, 
and I. Zanzi. 1981. Total body bone mineral and lean body mass 
by DPA. Comparison with total body calcium by neutron acti- 
vation. Calcif. Tiss. Int. 33:365. 
84. RCRP dose 11 it. 1980. ~Radiolo iss:746. 
85. Mazess, R. B. , W. W. Peppier, J. E. Harrison, and K. G. McNiell 
1981. Total body bone mineral and lean body mass by DPAIII. 
Comparison with trunk Ca by neutron activation. Calcif. Tiss. 
Int, 33:365. 
86. Corey and Hayes. Diet for the adult cebus monkey. 1973. Report 
of the Nutrition Dept. , Harvard University, Boston, MA. 
87. Morgan, W. , K. J. Ellis, and S. H. Cohn. 1981. A comparison of 
Cf, Pu and Be neutron sources for partial body in viva neutron 
activation analysis. ~Ph s. Med. Biol. 26:413. 
88. Foster, L. B. , and R. T. Dunn. 1971. Single antibody technique 
for radioimmunoassay of cortisol in unextracted serum or plasma. 
Clin. Chem. 2D:365. 
89. Humason, G. L. 1962. Animal Tissue Techni ues. Freeman and Co. , 
San Francisco. 
9D. Ostle, B. 1963. Statistics in Research. Iowa State University 
Press, Ames, Iowa. 
91. Siegel, S. 1956. Non-Parametric Statistics. McGraw-Hill, Ko- 
gakusha, Japan. 
92. Gilman, G. G. , L. S. Goodman, and A. Gilman (eds. ). 198D. The 
harmacolo ical basis of thera eutics, 6th ed. MacMillan, New 
York. 
93. Ettinger, S. E. 1983. Textbook of Veterinar Internal Medicine. 
W. B. Saunders, Philadelphia. 
94. LoCascio, V. , E. Bonucci, S. Adami, and P. Ballenti. 1982. 
Glucocorticoid-induced osteopenia in long-term treated patients: 
prednisolone vs deflazacort. Calcif. Tiss. Int. 
~Su l. 34:29. 
95. Nagant de Deuxchaisnes, C. , and J. Devogelaar. 1982. Effect of 
glucocorticoids on bone. Calcif. Tiss. Int. 
~Su l. 34:8. 
96. Assandri, A. , P. Fernari, and E. Mortinelli. 1982. Disposition 
and metabolism of a glucocorticoid, deflazacort, in rats, dogs, 
monkeys and man. Calcif. Tiss. Int. ~Su l. 34:49. 
66 
97. Seal, U. , and R. Doe. 1965. Vertebrate distribution of 
corticosteroid-binding globulin and some endocrine effects on 
concentration. Steroids 5:827. 
98. Wilson, E. , and M. Jawed. 1981. CBG as a biological assay for 
endogenous estrogen in patients with and without endometrial 
carcinoma. Am. J. Obst. 
~G necol. 139:661. 
67 
VITA 
Scott Howard Loeffler was born on February 24, 1953 in Oklahoma 
City, Oklahoma. The son of Mr. and Mrs. W. B. Loeffler, he attended 
Casady School in the same city. In 1971, he began course work at 
Vanderbilt University (Nashville, Tennessee) from which he received 
his Bachelor of Science degree in Chemistry. In the spring of 1976, 
he began a course of study in the Department of Veterinary Public 
Health at the Texas AaM College of Veterinary Medicine. His research 
during this period was under the guidance of Dr. Leon Russell and is 
the subject of this thesis. After working a short time at the U. S. 
Army Natick Research Labs (Natick, Massachusetts), he began the pro- 
fessional veterinary curriculum at the State University of Utrecht 
(Utrecht, The Netherlands). In August 1981, he received the Drs. 
degree (= American D. V. M. ). Since this time he has done research at 
the Small Animal Clinic at the State University of Utrecht and 
completed a specialization in Tropical Animal Health. He is now 
working on a research project on rabies in Mexico at the Instituto 
Nacional de Investigaciones Pecuarias. His permanent address is: 
1425 Westchester, Oklahoma City, Oklahoma 73120. 
2488 
